BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3017644)

  • 1. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 7. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 10. Herpesvirus hominis: from latency to carcinogenesis?
    Aurelian L
    Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
    [No Abstract]   [Full Text] [Related]  

  • 11. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
    Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
    Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms.
    Eglin RP; Sharp F; MacLean AB; Macnab JC; Clements JB; Wilkie NM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3597-603. PubMed ID: 6167349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-immunological investigations in patients with cervical cancer: higher rate of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-1 antigen.
    Schneweis KE; Haag A; Lehmköster A; Koenig U
    IARC Sci Publ (1971); 1975; (11 Pt 2):53-7. PubMed ID: 191383
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
    Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
    Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
    Heise ER; Kucera LS; Raben M; Homesley H
    Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of herpes simplex-associated antigens and antibodies in patients with cervical carcinoma in Buenos Aires.
    Teyssié AR; Ayerra de Holstein B; Alonio L; Distéfano A; Lucero J; Pasqualini RS; de Torres RA
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):123-7. PubMed ID: 6258793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)].
    Fan J; Zeng Y; Liu YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb; 4(1):50-2. PubMed ID: 6279319
    [No Abstract]   [Full Text] [Related]  

  • 19. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
    Mendis LN; Best JM; Banatvala JE
    Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
    [No Abstract]   [Full Text] [Related]  

  • 20. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
    Rawls WE; Adam E; Melnick JL
    Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.